EquityZen Growth Technology Fund LLC - Series 1826
Raised
$334K
Investors
13
Min Invest
$10,006
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1826 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett on 2023-10-19. The vehicle raised $334K from 13 investors under Rule 506(b) and Section 3(c)(1) exemptions, with a $10K minimum investment. It is part of EquityZen's platform of 1,889 pre-IPO investment entities.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption structure typical of accredited investor pooled vehicles targeting private company equity. The $10K minimum is at the lower end for this asset category, consistent with retail-accessible pre-IPO platforms that aggregate smaller checks into company-specific SPVs.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
